APA Zitierstil

Coppin, C. (2010). Everolimus: The first approved product for patients with advanced renal cell cancer after sunitinib and/or sorafenib. Dove Medical Press.

Chicago Zitierstil

Coppin, Chris. Everolimus: The First Approved Product for Patients With Advanced Renal Cell Cancer After Sunitinib And/or Sorafenib. Dove Medical Press, 2010.

MLA Zitierstil

Coppin, Chris. Everolimus: The First Approved Product for Patients With Advanced Renal Cell Cancer After Sunitinib And/or Sorafenib. Dove Medical Press, 2010.

Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.